TREATMENT OF AMENORRHEA-GALACTORRHEA OR SEXUAL DYSFUNCTION

闭经、溢乳或性功能障碍的治疗

• 批准号: 3905552
• 负责人: SHAWKY BADAWY
• 金额: --
• 依托单位: UPSTATE MEDICAL UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3905552
• 关键词: drug adverse effect; human subject; human therapy evaluation; menstrual cycle disorder; neoplasm /cancer chemotherapy; pergolide; pituitary neoplasms; prolactin; reproductive system disorder chemotherapy; secretion; sex behavior disorder

This is a clinical trial of pergolide mesylate in patients with prolactin secreting pituitary tumors who have had a previous trial of bromocriotine that was ineffective in decreasing serum prolactin levels. The trial requires tests before, during and after daily administration of pergolide for one year. These tests are needed to determine any side effects, prolactin levels, and tumor size.

这是一项甲磺酸培高利特治疗 泌乳素分泌垂体瘤的患者， 溴隐亭对降低血清催乳素水平无效。 试验要求在每日给药前、给药期间和给药后进行检测 培高利特一年。这些测试需要确定任何一方 影响、催乳素水平和肿瘤大小。